|

Amino Acid infusion Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since July 2026

Also known as: Trophamine(TM) 10%

Pipeline

Phase 2: 1Phase 1/2: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Dana Fuhrman1

Indications

  • Heart Disease1
  • Gastroenteropancreatico Tumors1
  • Mechanical Ventilation1
  • Neuroendocrine Neoplasms1
  • Acute Kidney Injury1

Bethesda, Maryland1 trial

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

National Institutes of Health Clinical Center

Phase 1/2

Cincinnati, Ohio1 trial

Biomarker and Renal Angina Validation to Assess Heart-Kidney Outcomes After Amino Acid Therapy

Cincinnati Children's Hospital Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.